{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:19:53Z","timestamp":1791256793532,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Diagnostics Karolinska University Hospital."},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>High-grade and relevant strictures have recently been introduced in clinical guidelines for primary sclerosing cholangitis (PSC). However, the definition of relevant strictures differs between the two liver associations (AASLD, EASL). We aim to assess the prevalence, the agreement of identification of extrahepatic, high-grade, and relevant strictures, and their association with outcomes in PSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>In this retrospective single-center study, three radiologists, independently and in consensus, assessed MRCPs of 170 PSC individuals for the presence of extrahepatic and high-grade strictures. Interreader agreement was calculated with Fleiss kappa. Association of extrahepatic, high-grade, and relevant strictures with outcomes (hepatobiliary malignancy, liver transplantation, liver-related death) was assessed with Cox-regression, and outcome-free survival estimates with Kaplan\u2013Meier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age was 40 years, and 62% were males. One hundred-seven (63%) individuals had high-grade strictures, 49 (29%), and 53 (31%) had relevant strictures according to EASL and AASLD, respectively. During the median follow-up of 10.3 years, 50 individuals developed outcomes (liver transplantation = 37, liver-related death = 5, hepatobiliary malignancy = 8). Agreement for high-grade strictures was fair (k\u2009=\u20090.31). All strictures types were associated with worse prognosis in the univariate and multivariate analysis with extrahepatic strictures having hazard ratio (HR)\u2009=\u20093.34 (95% CI: 1.42\u20137.86), high-grade strictures HR\u2009=\u20092.00 (95% CI: 1.02\u20133.90), relevant strictures according to EASL and AASLD had HR\u2009=\u20092.43 (95% CI: 1.34\u20134.42) and HR\u2009=\u20092.89 (95% CI:1.57\u20135.32), respectively, after adjusting for Mayo Risk Score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prevalence of high-grade strictures is high, but the agreement of their identification is unsatisfactory. High-grade and relevant strictures, regardless of their definition (EASL or AASLD), were associated with a worse prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>What is the prevalence and the interreader agreement of high-grade and relevant strictures? Are they associated with a worse prognosis in PSC?<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>High-grade and relevant strictures are relatively common in PSC and are associated with a worse prognosis; however, the agreement of their identification is unsatisfactory<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>High-grade and relevant strictures have a role in clinical practice; however, the low interreader agreement of the interpretation of MRCP of individuals with PSC remains an unmet challenge<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12426-6","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:03:32Z","timestamp":1773399812000},"page":"5787-5795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence, interreader agreement, and prognostic value of high-grade and relevant strictures in individuals with primary sclerosing cholangitis"],"prefix":"10.1007","volume":"36","author":[{"given":"Stefan","family":"Hamma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3760-3513","authenticated-orcid":false,"given":"Aristeidis","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"12426_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M (2017) Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol 67:1298\u20131323","journal-title":"J Hepatol"},{"key":"12426_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2214\/ajr.145.5.1061","volume":"145","author":"GR May","year":"1985","unstructured":"May GR, Bender CE, LaRusso NF, Wiesner RH (1985) Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR Am J Roentgenol 145:1061\u20131064","journal-title":"AJR Am J Roentgenol"},{"key":"12426_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","volume":"51","author":"G Rudolph","year":"2009","unstructured":"Rudolph G, Gotthardt D, Kloters-Plachky P, Kulaksiz H, Rost D, Stiehl A (2009) Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol 51:149\u2013155","journal-title":"J Hepatol"},{"key":"12426_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","volume":"24","author":"MH Chapman","year":"2012","unstructured":"Chapman MH, Webster GJ, Bannoo S, Johnson GJ, Wittmann J, Pereira SP (2012) Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol 24:1051\u20131058","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"12426_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","volume":"161","author":"CY Ponsioen","year":"2021","unstructured":"Ponsioen CY, Assis DN, Boberg KM et al (2021) Defining primary sclerosing cholangitis: results from an International Primary Sclerosing Cholangitis Study Group consensus process. Gastroenterology 161:1764\u20131775.e1765","journal-title":"Gastroenterology"},{"key":"12426_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A et al (2023) AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 77:659\u2013702","journal-title":"Hepatology"},{"key":"12426_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH et al (2022) Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 32:923\u2013937","journal-title":"Eur Radiol"},{"key":"12426_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"O Chazouilleres","year":"2022","unstructured":"Chazouilleres O, Beuers U, Bergquist A et al (2022) EASL clinical practice guidelines on sclerosing cholangitis. J Hepatol 77:761\u2013806","journal-title":"J Hepatol"},{"key":"12426_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102526","volume":"70","author":"M Cornillet","year":"2024","unstructured":"Cornillet M, Villard C, Rorsman F et al (2024) The Swedish initiative for the study of primary sclerosing cholangitis (SUPRIM). EClinicalMedicine 70:102526","journal-title":"EClinicalMedicine"},{"key":"12426_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","volume":"78","author":"C Villard","year":"2023","unstructured":"Villard C, Friis-Liby I, Rorsman F et al (2023) Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. J Hepatol 78:604\u2013613","journal-title":"J Hepatol"},{"key":"12426_CR11","doi-asserted-by":"publisher","first-page":"109884","DOI":"10.1016\/j.ejrad.2021.109884","volume":"142","author":"A Grigoriadis","year":"2021","unstructured":"Grigoriadis A, Ringe KI, Andersson M, Kartalis N, Bergquist A (2021) Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol 142:109884","journal-title":"Eur J Radiol"},{"key":"12426_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"12426_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1037\/h0031619","volume":"76","author":"JL Fleiss","year":"1971","unstructured":"Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76:378\u2013382","journal-title":"Psychol Bull"},{"key":"12426_CR14","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1007\/s00330-023-09915-3","volume":"33","author":"S Poetter-Lang","year":"2023","unstructured":"Poetter-Lang S, Messner A, Bastati N et al (2023) Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. Eur Radiol 33:9022\u20139037","journal-title":"Eur Radiol"},{"key":"12426_CR15","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/liv.15985","volume":"44","author":"M Thylin","year":"2024","unstructured":"Thylin M, F\u00e4rkkil\u00e4 M, Kautiainen H et al (2024) The new definition of dominant stricture in primary sclerosing cholangitis: prevalence and clinical significance. Liver Int 44:2351\u20132358","journal-title":"Liver Int"},{"key":"12426_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouilleres O, Arrive L (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59:242\u2013250","journal-title":"Hepatology"},{"key":"12426_CR17","doi-asserted-by":"publisher","unstructured":"Lemoinne S, Cazzagon N, El Mouhadi S et al (2019) Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2019.03.013","DOI":"10.1016\/j.cgh.2019.03.013"},{"key":"12426_CR18","doi-asserted-by":"publisher","first-page":"100595","DOI":"10.1016\/j.jhepr.2022.100595","volume":"4","author":"A Grigoriadis","year":"2022","unstructured":"Grigoriadis A, Imeen Ringe K, Bengtsson J et al (2022) Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis. JHEP Rep 4:100595","journal-title":"JHEP Rep"},{"key":"12426_CR19","doi-asserted-by":"publisher","unstructured":"Poetter-Lang S, Ba-Ssalamah A, Messner A et al (2024) Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-10787-4","DOI":"10.1007\/s00330-024-10787-4"},{"key":"12426_CR20","doi-asserted-by":"publisher","unstructured":"Grigoriadis A, Morsbach F, Voulgarakis N, Said K, Bergquist A, Kartalis N (2020) Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging\/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis. Scand J Gastroenterol. https:\/\/doi.org\/10.1080\/00365521.2020.1720281:1-8","DOI":"10.1080\/00365521.2020.1720281:1-8"},{"key":"12426_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apt.14797","volume":"48","author":"R Zenouzi","year":"2018","unstructured":"Zenouzi R, Liwinski T, Yamamura J et al (2018) Follow-up magnetic resonance imaging\/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther 48:169\u2013178","journal-title":"Aliment Pharmacol Ther"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12426-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12426-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12426-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:17:44Z","timestamp":1781864264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12426-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["12426"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12426-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Aristeidis Grigoriadis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"A.G. is a member of the Scientific Editorial Board of\n                      European Radiology\n                      (section: Gastrointestinal-Abdominal) and, as such, did not participate in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Most of the study subjects or cohorts have been previously reported. None of the previous studies evaluated the presence of high-grade strictures and relative strictures and their association with clinical outcomes in individuals with primary sclerosing cholangitis.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}